Two Ipilimumab Trials Show Survival Benefit, and More Toxicity Two Ipilimumab Trials Show Survival Benefit, and More Toxicity

Dr Weber discusses two studies that show a clear survival advantage with ipilimumab, but at a significant price in toxicity.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news